Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent manner

B L Probst1, L Liu, V Ramesh

  • 1Joyant Pharmaceuticals Inc., Dallas, TX 75207, USA.

Insights

Smac mimetics combined with chemotherapy enhance cancer cell death by activating TNF-α signaling. This combination therapy shows promise for treating tumors by promoting apoptosis and tumor regression.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Pharmacology

Background:

  • Second mitochondria-derived activator of caspase (Smac) is a mitochondrial protein.
  • Smac mimetics are emerging therapeutics that induce apoptosis in cancer cells.
  • Smac mimetic efficacy depends on XIAP neutralization and cancer cell autocrine TNF-α production.

Purpose of the Study:

  • To investigate the utility of Smac mimetics in combination with conventional chemotherapy.
  • To elucidate the mechanisms underlying the synergistic effects of Smac mimetic and chemotherapy combinations.
  • To evaluate the therapeutic potential of Smac mimetics in preclinical cancer models.

Main Methods:

  • In vitro studies assessing caspase activation and cell death.
  • Analysis of autocrine TNF-α feedback loops.
  • In vivo studies using xenograft mouse models.

Main Results:

  • Smac mimetics combined with chemotherapy exacerbate caspase activation and induce cancer cell death.
  • The combination therapy involves chemotherapy-induced cell proliferation inhibition and Smac mimetic-enhanced autocrine TNF-α signaling.
  • Synergism is mediated via a TNF-α/RIP1-dependent pathway, activating the extrinsic apoptotic pathway, not the intrinsic pathway.
  • Autocrine TNF-α contributes to Smac mimetic-induced tumor regression in vivo.

Conclusions:

  • Smac mimetic and chemotherapy combinations offer a potent antineoplastic strategy.
  • The synergistic effect is driven by the extrinsic apoptotic pathway activation.
  • These findings support the translational application of Smac mimetic/chemotherapy combinations for cancer treatment.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...